3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Lung Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Chordoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Advanced Solid Malignancies
1
Advanced Liver Cancers
1
Interventions
Temozolomide
41
Magnetic Resonance Spectroscopy
21
Radiotherapy
19
Specimen Handling
15
Radiation
12
Bevacizumab
11
Lomustine
9
pembrolizumab
6
fludarabine
5
Surgical Procedures, Operative
5
atezolizumab
4
Nivolumab
4
Ipilimumab
4
Cyclophosphamide
4
Carboplatin
4
Biopsy
4
cemiplimab
3
azeliragon
3
Immunoglobulin G
3
Disulfides
3
Aminolevulinic Acid
3
veliparib
2
trametinib
2
rocakinogene sifuplasmid
2
ribociclib
2
poly ICLC
2
pamiparib
2
olaparib
2
niraparib
2
lutetium Lu 177 dotatate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Tiragolumab
×
90 days
×
Clear all
No trials found.